VOYA Investment Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$983K Sell
10,207
-77
-0.7% -$7.7K ﹤0.01% 1456
2025
Q4
$1M Buy
10,284
+140
+1% +$12K ﹤0.01% 1476
2025
Q3
$722K Sell
10,144
-1,482
-13% -$98.7K ﹤0.01% 1595
2025
Q2
$695K Sell
11,626
-85
-0.7% -$4.66K ﹤0.01% 1737
2025
Q1
$615K Buy
11,711
+3,239
+38% +$182K ﹤0.01% 1770
2024
Q4
$466K Sell
8,472
-421
-5% -$22.2K ﹤0.01% 1969
2024
Q3
$447K Buy
8,893
+2,711
+44% +$125K ﹤0.01% 2059
2024
Q2
$272K Buy
6,182
+686
+12% +$29.2K ﹤0.01% 2303
2024
Q1
$242K Sell
5,496
-994
-15% -$43.9K ﹤0.01% 2364
2023
Q4
$308K Buy
+6,490
New +$273K ﹤0.01% 2332

Other funds holding IRMD

VOYA Investment Management's IRMD Position: Q1 2026 in Review

VOYA Investment Management reduced its iRadimed (IRMD) stake by 0.75% in Q1 2026, selling an estimated $7.7K and leaving 10,207 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

VOYA Investment Management first reported a position in IRMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $1M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • VOYA Investment Management held 10,207 shares of iRadimed worth $983K as of Q1 2026.
  • VOYA Investment Management sold 77 iRadimed shares in Q1 2026, an estimated $7.7K.
  • iRadimed made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1456 holding.
  • VOYA Investment Management first reported a position in iRadimed in Q4 2023 and has held it in 10 quarters since.
  • VOYA Investment Management's iRadimed position peaked at $1M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.